Key takeaways from Outsourcing in Clinical trials Nordics 2019
Outsourcing in Clinical Trials Nordics was arranged in Copenhagen on the 22 and 23 October. Ilari Jauro, Project Manager for Clinical Services at Oriola, was one of our experts participating the event. Jauro has almost 30 years of experience in clinical trials. He, together with Oriola´s Clinical Services team, helps pharmaceutical companies with comprehensive solutions in clinical trials in the Nordics.
“Successful collaboration with pharmaceutical companies in clinical trials requires strong expertise and wide experience to find the best solution for each situation. It was a pleasure to participate the event once again and have interesting discussions with pharmaceutical companies”, says Jauro.
Here are Jauro´s three key takeaways from the event:
- Pharmaceutical companies continue to outsource clinical trial activities to Clinical Research Organisations (CRO) as usual. Depending on the size of the company and available resources, companies outsource either all the clinical trial activities (feasibilities, protocol writing, submissions to CA and EC, monitoring, reporting etc.) or just part of those. Nowadays, pharmaceutical companies emphasize more and more the importance of oversight management of the CRO´s.
- Pharmaceutical companies appreciate and require transparent and fluent collaboration with CRO´s. According to companies´ experiences, open communication and realistic schedules combined to solid expertise are the key elements in successful clinical trial projects.
- Real World Evidence has important role in data collection as it offers the possibility to gather reliable data directly from the patients.
Ritva Loponen, Head of Clinical Services is happy to tell you how we can support you in clinical trials in the Nordics.